Efficacy and safety of long-acting intramuscular testosterone undecanoate in aging men: a randomised controlled study (Q51013519)

27 March 2018

title

Efficacy and safety of long-acting intramuscular testosterone undecanoate in aging men: a randomised controlled study (English)

1 reference

27 March 2018

1 reference

2

1 reference

27 March 2018

author name string

Wei Shen Tan

1

1 reference

27 March 2018

Chirk Jenn Ng

3

1 reference

27 March 2018

Wei Keith Tan

4

1 reference

27 March 2018

Seng Fah Tong

5

1 reference

27 March 2018

Christopher Ho

6

1 reference

27 March 2018

Ee Ming Khoo

7

1 reference

27 March 2018

George Lee

8

1 reference

27 March 2018

Boon Cheok Lee

9

1 reference

27 March 2018

Verna Lee

10

1 reference

27 March 2018

Hui Meng Tan

11

1 reference

27 March 2018

publication date

12 April 2013

1 reference

27 March 2018

published in

BJU International

1 reference

27 March 2018

volume

111

1 reference

27 March 2018

issue

7

1 reference

27 March 2018

page(s)

1130-1140

1 reference

27 March 2018

Prevalence of hypogonadism in males aged at least 45 years: the HIM study

cites work

1 reference

Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease

21 January 2018

1 reference

Hypothalamic-pituitary gonadal dysfunction in renal failure, dialysis and renal transplantation

21 January 2018

1 reference

Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes

21 January 2018

1 reference

Clinical review: Why is androgen replacement in males controversial?

21 January 2018

1 reference

Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations

21 January 2018

1 reference

Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle

21 January 2018

1 reference

Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline

21 January 2018

1 reference

Transdermal drug delivery systems and skin sensitivity reactions. Incidence and management

21 January 2018

1 reference

Hyperandrogenism after transfer of topical testosterone gel: case report and review of published and unpublished studies

21 January 2018

1 reference

The efficacy and safety of testosterone undecanoate (Nebido(®)) in testosterone deficiency syndrome in Korean: a multicenter prospective study

21 January 2018

1 reference

Effect of long-acting testosterone undecanoate treatment on quality of life in men with testosterone deficiency syndrome: a double blind randomized controlled trial

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled trial on the effect of long-acting testosterone treatment as assessed by the Aging Male Symptoms scale

21 January 2018

1 reference

The triad of erectile dysfunction, testosterone deficiency syndrome and metabolic syndrome: findings from a multi-ethnic Asian men study (The Subang Men’s Health Study)

21 January 2018

1 reference

The impact of assay quality and reference ranges on clinical decision making in the diagnosis of androgen disorders

21 January 2018

1 reference

Treatment of 161 Men with Symptomatic Late Onset Hypogonadism with Long-Acting Parenteral Testosterone Undecanoate: Effects on Body Composition, Lipids, and Psychosexual Complaints

21 January 2018

1 reference

Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men: the Health In Men Study

21 January 2018

1 reference

Androgen therapy improves insulin sensitivity and decreases leptin level in healthy adult men with low plasma total testosterone: a 3-month randomized placebo-controlled trial

21 January 2018

1 reference

Effects of acute hyperinsulinemia on testosterone serum concentrations in adult obese and normal-weight men.

21 January 2018

1 reference

Waist circumference and testosterone levels in community dwelling men. The Tromsø study

21 January 2018

1 reference

Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study

21 January 2018

1 reference

Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial

21 January 2018

1 reference

Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis

21 January 2018

1 reference

Adverse events associated with testosterone administration

21 January 2018

1 reference

IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 men.

21 January 2018

1 reference

Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study).

21 January 2018

1 reference

Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis

21 January 2018

1 reference

Risks of testosterone-replacement therapy and recommendations for monitoring

21 January 2018

1 reference

Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study

21 January 2018

1 reference

Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies

21 January 2018

1 reference

Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial

21 January 2018

1 reference

Managing the Risks of Prostate Disease During Testosterone Replacement Therapy in Older Men: Recommendations for a Standardized Monitoring Plan

21 January 2018

1 reference

Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled study.

21 January 2018

1 reference

Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy alone

21 January 2018

1 reference

Testosterone therapy in erectile dysfunction and hypogonadism

21 January 2018

1 reference

Comparison of a new long-acting testosterone undecanoate formulation vs testosterone enanthate for intramuscular androgen therapy in male hypogonadism

21 January 2018

1 reference

Liver pathology associated with the use of anabolic-androgenic steroids

21 January 2018

1 reference

A four-year efficacy and safety study of the long-acting parenteral testosterone undecanoate

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJU.12037

1 reference

27 March 2018

1 reference

27 March 2018